Volume : 11, Issue : 05, May – 2024
Title:
FORMULATION AND DEVELOPMENT OF NOVEL CONTROL RELEASE TRANSDERMAL PATCHES of BUPRANOLOL
Authors :
Jansan Bharti, Dr. B. K. Dubey, Deepak Basedia, Mukesh Kumar Patel
Abstract :
Transdermal drug delivery systems offer several advantages over conventional oral or parenteral routes, including improved patient compliance, sustained drug release, and reduced systemic side effects. In this study, we aimed to formulate and develop novel controlled-release transdermal patches of Bupranolol, a beta-blocker used in the management of hypertension and angina. The patches were prepared using the solvent casting method, employing hydrophilic polymers such as carboxymethyl cellulose sodium (CMC-Na) and hydroxypropyl methylcellulose (HPMC) dissolved in a solvent mixture of ethanol and distilled water. Bupranolol was incorporated into the polymer matrix along with plasticizers such as glycerin, polyvinylpyrrolidone (PVP), and polyethylene glycol 400 (PEG400) to enhance flexibility and drug release kinetics. The formulations were characterized for various parameters including particle size, surface morphology, drug loading, encapsulation efficiency, in vitro release kinetics, and skin irritation potential. The optimized formulation exhibited desirable characteristics, including sustained drug release over 24 hours, good mechanical properties, and minimal skin irritation. In conclusion, the developed transdermal patches of Bupranolol hold promise as a novel drug delivery system for the controlled release of this cardiovascular medication, offering potential benefits in terms of improved therapeutic efficacy and patient compliance.
Keywords: Transdermal patches, Controlled release, Bupranolol, Solvent casting method, Hydrophilic polymers, Chitosan, Glycerin, Polyvinylpyrrolidone (PVP).
Cite This Article:
Please cite this article in press Jansan Bharti et al., Formulation And Development Of Novel Control Release Transdermal Patches Of Bupranolol., Indo Am. J. P. Sci, 2024; 11 (05).
Number of Downloads : 10
References:
1. Prausnitz, M.R., Langer, R. (2008). Transdermal drug delivery. Nature Biotechnology, 26(11), 1261-1268.
2. Narang, A.S., Delmarre, D., Gao, D. (2007). Stable drug encapsulation in micelles and microemulsions. International Journal of Pharmaceutics, 345(1-2), 9-25.
3. Singh, B., Ahuja, N., Saharan, V.A. (2011). Exploring the potential of novel drug delivery systems for herbal drugs. Expert Opinion on Drug Delivery, 8(1), 7-27.
4. Li, X., Zhao, R., Liu, S. (2013). Strategies to improve micelle stability for drug delivery. Nano Today, 8(5), 468-487.
5. Mitragotri, S., Anissimov, Y.G., Bunge, A.L. (2011). Mathematical models of skin permeability: an overview. International Journal of Pharmaceutics, 418(1), 115-129.
6. Williams, A.C., Barry, B.W. (2012). Penetration enhancers. Advanced Drug Delivery Reviews, 64, 128-137.
7. Benson, H.A.E. (2005). Transdermal drug delivery: penetration enhancement techniques. Current Drug Delivery, 2(1), 23-33.
8. Patel, V.F., Liu, F., Brown, M.B. (2017). Advances in oral transmucosal drug delivery. Journal of Controlled Release, 255, 1-11.
9. Ghosh, P., Ghosh, S., Basu, S. (2016). Nanoparticle therapeutics: state-of-the-art and limitations to clinical translation. Current Pharmaceutical Design, 22(19), 2826-2839.